Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.

Ayodeji, Saheed A; Bao, Bin; Teslow, Emily A; Polin, Lisa A; Dyson, Greg; Bollig-Fischer, Aliccia; Fehl, Charlie

Ayodeji, Saheed A; Bao, Bin; Teslow, Emily A; Polin, Lisa A; Dyson, Greg; Bollig-Fischer, Aliccia; Fehl, Charlie.

Afiliação

Ayodeji SA; Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI, USA.
Bao B; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Teslow EA; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Polin LA; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Dyson G; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Bollig-Fischer A; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA.
Fehl C; Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, MI, USA. charlie.fehl@wayne.edu.

Cancer Cell Int ; 23(1): 102, 2023 May 25.

Article em En | MEDLINE | ID: mdl-37231419

Palavras-chave

Chemical biology; Epigenetics; Glycobiology; Hyperglycemia; Metabolic disease; O-GlcNAc transferase; Obesity; TET1; TNBC; Tumorigenesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google